Brad Barnett
Chief Tech/Sci/R&D Officer en COGENT BIOSCIENCES, INC. .
Perfil
Brad Barnett is currently the Chief Technology Officer at Cogent Biosciences, Inc. Prior to his current position, he worked at Array BioPharma, Inc. from 2000 to 2019, where he held the position of Vice President-Supply Chain & Manufacturing from 2015 to 2019.
Mr. Barnett received an undergraduate degree from Colorado State University and an MBA from The University of Colorado.
Cargos activos de Brad Barnett
| Empresas | Cargo | Inicio |
|---|---|---|
| COGENT BIOSCIENCES, INC. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Brad Barnett.
| Empresas | Cargo | Fin |
|---|---|---|
| ARRAY TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/08/2019 |
Formación de Brad Barnett.
| Colorado State University | Undergraduate Degree |
| The University of Colorado | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| COGENT BIOSCIENCES, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Array BioPharma, Inc. is a biopharmaceutical company. Its focus is on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer and other high-burden diseases. The company's products are BRAFTOVI and MEKTOVI. Its portfolio includes Binimetinib, Selumetinib, Encorafenib, Filanesib, Ipatasertib, Varltinib, Danoprevir, ARRY-797, Larotrectinib, Tucatinib, ARRY-382, Motolimod, Prexasertib, GDC-0575, LOXO-292, LOXO-195, and AK-1830. The company was founded by Kevin Koch, Anthony D. Piscopio, K. C. Nicolaou, and David L. Snitman in 1998 and is headquartered in Boulder, CO. | Health Technology |
- Bolsa de valores
- Insiders
- Brad Barnett
